Innovation Pharmaceuticals Inc (IPIX)

[BonelessCat]

Not saying this is the case, but since the board is tossing around numbers: assuming fully diluted the share count is ~250 million, a billion dollar offer would net ~$4 a share. Yes, I’d take that.

However, B-UP and -OM together would net ~$1 billion in upfront and potential milestones to market. How that filters out depends on perceived risk for the licensee. 90%-95% of the risk would be structured in the back end: benchmarks, milestones and after market royalties.

Nonetheless, there would still be the rest of the IBD (assuming IBD was not in the package) left to negotiate along with oral K.

$1-$2 billion buyout does seem fair at this point.